Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application.
Stem Cell Res
; 17(2): 379-390, 2016 09.
Article
en En
| MEDLINE
| ID: mdl-27639108
ABSTRACT
From 2006 to 2011, Roslin Cells Ltd derived 17 human embryonic stem cells (hESC) while developing (RCM1, RC-2 to -8, -10) and implementing (RC-9, -11 to -17) quality assured standards of operation in a facility operating in compliance with European Union (EU) directives and United Kingdom (UK) licensure for procurement, processing and storage of human cells as source material for clinical application, and targeted to comply with an EU Good Manufacturing Practice specification. Here we describe the evolution and specification of the facility, its operation and outputs, complementing hESC resource details communicated in Stem Cell Research Lab Resources.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Técnicas de Cultivo de Célula
/
Células Madre Embrionarias Humanas
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Stem Cell Res
Año:
2016
Tipo del documento:
Article